Acute Lymphoblastic Leukemia in a Patient Treated with Letrozole and Palbociclib / 한국유방암학회지
Journal of Breast Cancer
;
: 100-106, 2020.
Article
in English
| WPRIM
| ID: wpr-811192
ABSTRACT
Palbociclib, in conjunction with endocrine therapy, has been approved for the treatment of patients with advanced breast cancer. The common hematological toxicities associated with palbociclib are leukopenia and neutropenia. However, hematological malignancies have not been reported for palbociclib treatment. Here, for the first time, we present a case of acute lymphoblastic leukemia that was diagnosed in a patient undergoing treatment with letrozole and palbociclib for metastatic breast cancer. This case emphasizes the need for long term follow up of patients treated with palbociclib.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Breast Neoplasms
/
Follow-Up Studies
/
Hematologic Neoplasms
/
Precursor Cell Lymphoblastic Leukemia-Lymphoma
/
Leukopenia
/
Neutropenia
Type of study:
Observational study
/
Prognostic study
/
Risk factors
Limits:
Humans
Language:
English
Journal:
Journal of Breast Cancer
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS